Annual Statements Open main menu

Inrad Optics, Inc. - Quarter Report: 2004 September (Form 10-Q)

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

 

FORM 10-Q

(Mark One)

 

ý

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

For the quarterly period ended SEPTEMBER 30, 2004

 

 

 

OR

 

 

 

o

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)  OF THE SECURITIES EXCHANGE ACT OF 1934

 

 

 

For the transition period from                      to                     

 

Commission file number 0-11668

 

Photonic Products Group, Inc.
(Exact name of registrant as specified in its charter)

 

New Jersey

 

22-2003247

(State or other jurisdiction of incorporation

 

(I.R.S. Employer

or organization)

 

Identification Number)

 

181 Legrand Avenue, Northvale, NJ  07647
(Address of principal executive offices)
(Zip Code)

 

(201) 767-1910
(Registrant’s telephone number, including area code)

 

 

 (Former name, former address and formal fiscal year, if changed since last report)

 

                Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes ý  No o

 

Common shares of stock outstanding as of September 30, 2004:

 

7,156,303

 

 



 

Photonic Products Group, Inc.

 

INDEX

 

Part I.

FINANCIAL INFORMATION

 

 

 

 

 

 

Item 1.

Financial Statements:

 

 

 

 

 

 

 

Consolidated Balance Sheets as of September 30, 2004, (unaudited)
and December 31, 2003

 

 

 

 

 

 

 

Consolidated Statements of Operations for the Three and Nine
Months Ended September 30, 2004 and 2003 (unaudited)

 

 

 

 

 

 

 

Consolidated Statements of Cash Flows for the Nine
Months Ended September 30, 2004 and 2003 (unaudited)

 

 

 

 

 

 

 

Notes to Consolidated Financial Statements

 

 

 

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition
and Results of Operations

 

 

 

 

 

 

 

Liquidity and Capital Resources

 

 

 

 

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

 

 

 

 

 

 

Item 4.

Controls and Procedures

 

 

 

 

 

Part II.

OTHER INFORMATION

 

 

 

 

 

 

Item 2.

Changes in Securities, use of Proceeds and Issuer Purchases of Equity Securities

 

 

 

 

 

 

Item 4.

Submission of Matters to a Vote of Security Holders

 

 

 

 

 

 

Item 6.

Exhibits and Reports on Form 8-K

 

 

 

 

 

Signatures

 

 

 

 

 

Certifications — Sections 906 and 302

 

 



 

PHOTONIC PRODUCTS GROUP, INC AND SUBSIDIARIES

 

CONSOLIDATED BALANCE SHEETS

 

 

 

September 30,

 

December 31,

 

 

 

2004

 

2003

 

 

 

Unaudited

 

 

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

2,709,245

 

$

1,282,160

 

Accounts receivable (after allowance for doubtful accounts of $40,000 in 2004 and 2003)

 

1,455,860

 

973,415

 

Inventories

 

1,951,201

 

2,219,116

 

Unbilled contract costs

 

 

191,767

 

Other current assets

 

219,364

 

76,941

 

Total Current Assets

 

6,335,670

 

4,743,399

 

Plant and equipment,

 

 

 

 

 

Plant and equipment at cost

 

10,735,219

 

9,824,498

 

Less: Accumulated depreciation and amortization

 

(7,061,466

)

(6,572,278

)

Total plant and equipment

 

3,673,753

 

3,252,220

 

Precious Metals

 

309,565

 

309,565

 

Intangible Assets

 

443,750

 

443,750

 

Other Assets

 

276,996

 

102,187

 

Total Assets

 

$

11,039,734

 

$

8,851,121

 

 

 

 

 

 

 

Liabilities and Shareholders’ Equity

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

Note payable -Other

 

$

55,800

 

$

68,292

 

Accounts payable and accrued liabilities

 

1,219,768

 

993,150

 

Customer advances

 

390,091

 

 

Current obligations under capital leases

 

99,664

 

99,664

 

Total current liabilities

 

1,765,323

 

1,161,106

 

 

 

 

 

 

 

Secured and Convertible Notes Payable

 

5,200,000

 

4,200,000

 

Other Long Term Notes

 

74,818

 

116,728

 

Capital Lease Obligations

 

14,873

 

88,848

 

Total liabilities

 

7,055,014

 

5,566,682

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

10% convertible preferred stock, Series A no par value; 500 shares issued and outstanding respectively

 

500,000

 

500,000

 

 

 

 

 

 

 

10% convertible preferred stock, Series B no par value; 2,100 shares issued and outstanding respectively

 

2,100,000

 

2,100,000

 

 

 

 

 

 

 

Common stock: $.01 par value; 60,000,000 authorized 7,160,903 shares issued at September 30, 2004 and 5,445,953 issued December 31, 2003

 

70,269

 

54,459

 

Capital in excess of par value

 

10,879,302

 

9,534,523

 

Accumulated deficit

 

(9,549,901

)

(8,889,593

)

 

 

3,999,670

 

3,299,389

 

Less - Common stock in treasury, at cost (4,600 shares respectively)

 

(14,950

)

(14,950

)

Total Shareholders’ Equity

 

3,984,720

 

3,284,439

 

Total Liabilities & Shareholders’ Equity

 

$

11,039,734

 

$

8,851,121

 

 

See Notes to Consolidated Financial Statements

 

1



 

Photonic Products Group, Inc. and Subsidiaries

Consolidated Statements of Operations

(Unaudited)

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30

 

 

 

2004

 

2003

 

2004

 

2003

 

Total Revenue

 

$

2,582,372

 

$

1,405,663

 

$

6,305,495

 

$

3,753,633

 

 

 

 

 

 

 

 

 

 

 

Cost and Expenses:

 

 

 

 

 

 

 

 

 

Cost of goods sold

 

1,735,381

 

1,119,973

 

4,649,322

 

2,986,124

 

Selling, general & administrative expenses

 

645,932

 

570,842

 

2,007,438

 

1,664,870

 

Internal R & D expenses

 

24,344

 

34,992

 

76,440

 

115,903

 

Total Cost and Expenses

 

2,405,658

 

1,725,807

 

6,733,200

 

4,766,897

 

 

 

 

 

 

 

 

 

 

 

Operating profit (loss)

 

176,714

 

(320,144

)

(427,705

)

(1,013,264

)

 

 

 

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

 

 

 

Interest expense

 

(84,759

)

(57,880

)

(238,296

)

(165,059

)

Other

 

3,212

 

(2,449

)

5,698

 

1,522

 

 

 

 

 

 

 

 

 

 

 

Net Profit (Loss)

 

95,167

 

(380,473

)

(660,303

)

(1,176,801

)

 

 

 

 

 

 

 

 

 

 

Preferred stock dividends

 

 

 

 

(164,820

)

(53,600

)

 

 

 

 

 

 

 

 

 

 

Net profit (loss) applicable to common shareholders

 

$

95,167

 

$

(380,473

)

$

(825,123

)

$

(1,230,401

)

 

 

 

 

 

 

 

 

 

 

Net profit (loss) per common share - basic

 

$

0.01

 

$

(0.07

)

$

(0.14

)

$

(0.23

)

 

 

 

 

 

 

 

 

 

 

Net profit (loss) per common share - diluted

 

$

0.01

 

$

(0.07

)

$

(0.14

)

$

(0.23

)

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding-basic

 

7,148,318

 

5,283,690

 

6,034,755

 

5,283,690

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding-diluted

 

11,829,052

 

5,283,690

 

6,034,755

 

5,283,690

 

 

See Notes to Consolidated Financial Statements

 

2



 

PHOTONIC PRODUCTS GROUP, INC AND SUBSIDIARIES

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

 

 

Nine Months Ended September 30,

 

 

 

2004

 

2003

 

Cash flows from operating activities:

 

 

 

 

 

Net loss

 

$

(660,303

)

$

(1,176,801

)

 

 

 

 

 

 

Adjustments to reconcile net loss to cash provided by (used in) operating activities:

 

 

 

 

 

Depreciation and amortization

 

489,188

 

422,645

 

401K common stock contribution

 

 

11,870

 

Changes in assets and liabilities:

 

 

 

 

 

Accounts receivable

 

(482,445

)

417,067

 

Inventories

 

267,915

 

(60,173

)

Unbilled contract costs

 

191,767

 

177,191

 

Other current assets

 

(142,423

)

(3,369

)

Other assets

 

(174,809

)

(2,603

)

Accounts payable and accrued liabilities

 

226,618

 

111,114

 

Customer advances

 

390,091

 

 

 

 

 

 

 

 

 

Total adjustments

 

765,901

 

1,073,742

 

Net cash provided by (used in) operating activities

 

105,598

 

(103,059

)

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

Capital expenditures

 

(910,725

)

(86,259

)

 

 

 

 

 

 

Net cash used in investing activities

 

(910,725

)

(86,259

)

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

Proceeds from issuance of common stock

 

1,360,589

 

 

 

Proceeds from secured notes payable

 

 

 

1,700,000

 

Proceeds from senior convertible debenture

 

1,000,000

 

 

 

Principal payments of bank debt

 

 

 

(1,678,623

)

Principal payments of notes

 

(54,402

)

(112,425

)

Principal payments of capital lease obligations

 

(73,975

)

(76,300

)

 

 

 

 

 

 

Net cash provided by (used in) financing activities

 

2,232,212

 

(167,348

)

 

 

 

 

 

 

Net increase (decrease) in cash and cash equivalents

 

1,427,085

 

(356,666

)

 

 

 

 

 

 

Cash and cash equivalents at beginning of period

 

1,282,160

 

1,155,074

 

 

 

 

 

 

 

Cash and cash equivalents at end of period

 

$

2,709,245

 

$

798,408

 

 

See Notes to Consolidated Financial Statements

 

3



 

Photonic Products Group, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

September 30, 2004

(Unaudited)

 

NOTE 1 -SUMMARY OF ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying unaudited interim consolidated financial statements of Photonic Products Group, Inc. (the “Company”), reflect all adjustments, which are of a normal recurring nature, and disclosures which, in the opinion of management, are necessary for a fair statement of results for the interim periods.  It is suggested that these consolidated financial statements be read in conjunction with the audited consolidated financial statements as of December 31, 2003 and 2002 and for the years then ended and notes thereto included in the Company’s report on Form 10-K, filed with the Securities and Exchange Commission.

 

Inventory Valuation

 

Inventories are valued on a lower of cost (first-in-first-out basis) or market basis (net realizable value).  Work In Process inventory for the period is stated at actual cost, not in excess of estimated realizable value.

Inventories are comprised of the following:

 

 

 

September 30,

 

December 31,

 

 

 

2004

 

2003

 

Raw materials

 

$

558,829

 

$

543,116

 

Work in process, including manufactured parts and components

 

1,001,501

 

1,275,000

 

Finished goods

 

390,871

 

401,000

 

 

 

 

 

 

 

 

 

$

1,951,201

 

$

2,219,116

 

 

Income Taxes

 

The Company recognizes deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company’s financial statements or tax returns.  Deferred tax assets and liabilities are determined based on the difference between the financial statement carrying amounts and the tax bases of assets and liabilities using enacted tax rates in effect in the years in which the differences are expected to reverse.  A valuation allowance is established when deferred tax assets are not likely to be realized.

 

Net Income (Loss) Per Share

 

Basic and diluted net (loss) income per share is computed using the weighted average number of common shares outstanding for the period ended September 30, 2004.  The potential dilutive effect of securities, which are common share equivalents, options, warrants, convertible notes and convertible preferred stock and their associated dividends have been excluded from the diluted computation for the nine months ended in 2004 and 2003 and for the three months ended September 2003 because their effect is antidilutive.

 

The following is the reconciliation of the basic and diluted earnings-per-share computations required by Statement of Financial Accounting Standards (“SFAS”) No. 128 (“Earnings Per Share”):

 

4



 

 

 

Three Months Ended
September 30, 2004

 

Three Months Ended
September 30, 2003

 

 

 

Income
(Numerator)

 

Shares
(Denominator)

 

Per-Share
Amount

 

Income
(Numerator)

 

Shares
(Denominator)

 

Per Share
Amount

 

Basic Earnings Per Share:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income (loss) Applicable to Common Shareholders

 

$

95,167

 

7,148,318

 

$

0.01

 

$

(380,473

)

5,283,690

 

$

(0.07

)

Effect of dilutive securities

 

 

 

 

 

 

 

 

 

 

 

 

 

Convertible Debt

 

52,500

 

3,500,000

 

 

 

 

 

 

 

 

Convertible Preferred Stock

 

 

 

840,000

 

 

 

 

 

 

 

 

 

Options and Warrants

 

 

 

340,734

 

 

 

 

 

 

 

Diluted Earnings Per Share:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income (loss) Applicable to Common Shareholders

 

$

147,667

 

11,829,052

 

$

0.01

 

$

(380,473

)

5,283,690

 

$

(0.07

)

 

 

 

 

Nine Months Ended
September 30, 2004

 

Nine Months Ended
September 30, 2003

 

 

 

Income
(Numerator)

 

Shares
(Denominator)

 

Per-Share
Amount

 

Income
(Numerator)

 

Shares
(Denominator)

 

Per Share
Amount

 

Basic Earnings Per Share:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Loss Applicable to Common Shareholders

 

$

(825,123

)

6,034,755

 

$

(0.14

)

$

(1,230,401

)

5,283,690

 

$

(0.23

)

Effect of dilutive securities

 

 

 

 

 

 

 

 

 

 

 

 

 

Convertible debt

 

 

 

 

 

 

 

 

 

Options

 

 

 

 

 

 

 

 

 

Warrants

 

 

 

 

 

 

 

 

 

Diluted Earnings Per Share:

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Loss Applicable to Common Shareholders

 

$

(825,123

)

6,034,755

 

$

(0.14

)

$

(1,230,401

)

5,283,690

 

$

(0.23

)

 

5



 

Stock Based Compensation

 

The Company accounts for stock-based compensation arrangements in accordance with the provisions of Accounting Principles Board (“APB”) Opinion No. 25, Accounting for Stock Issued to Employees.  Accordingly, no compensation costs for options has been recognized in the financial statements.  The chart below sets forth the Company’s net profit (loss) per share for the nine and three months ended September 30, 2004 and 2003, as reported on a pro forma basis as if the compensation cost of stock options had been determined in accordance with SFAS 123.

 

 

 

For the three months ended
September 30,

 

For the nine months
end September 30,

 

 

 

2004

 

2003

 

2004

 

2003

 

Net Profit (Loss) applicable to common shareholders, as reported

 

$

95,167

 

$

(380,473

)

$

(825,123

)

$

(1,230,401

)

Deduct: Total stock-based employee compensation expense determined under fair value based method for all awards, net of related tax effects

 

(30,726

)

(58,115

)

(92,178

)

(174,345

)

 

 

 

 

 

 

 

 

 

 

Pro forma net profit (loss)

 

$

64,441

 

$

(438,588

)

$

(917,301

)

$

(1,404,746

)

 

 

 

 

 

 

 

 

 

 

Basic income(loss) per share:

 

 

 

 

 

 

 

 

 

As Reported

 

.01

 

(0.07

)

(.14

)

(.23

)

Pro forma

 

.01

 

(0.08

)

(.15

)

(.27

)

 

 

 

 

 

 

 

 

 

 

Diluted income (loss) per share:

 

 

 

 

 

 

 

 

 

As Reported

 

.02

 

(0.07

)

(.14

)

(.23

)

Pro forma

 

.01

 

(0.08

)

(.15

)

(.27

)

 

NOTE 2- CHANGES IN LONG TERM DEBT

 

At the end of the fourth quarter of 2002 the Company received $1,000,000 in proceeds from the issuance of a Subordinated Convertible Promissory Note.  The Note is due in January 2006 and bears an interest rate of 6%.  The note was amended in 2004 to clarify its conversion features.  Interest accrues yearly and along with principal may be converted into Common Stock, (and/or securities convertible into common shares), at a conversion rate equal to the purchase price of stock issued (and/or securities issued that are convertible into Common Stock) for cash after the date of the Note to an unrelated third party investor, or if no such issuance takes place within twenty four months of the date of the Note, at a price mutually agreed upon as fair value by the Issuer and Holder.  The Holder of the Note is a related party to a major shareholder of the Company.

 

In January 2003 the Company was in violation of certain financial covenants required under its loan agreements.  As a result Wachovia Bank sold both the asset based loan and working capital revolver to APC Investments.  In June of 2003 the Company paid off the loan held by APC with $1,700,000 in proceeds received from the issuance of a Secured Promissory Note that is held by a major investor in the Company.  The Secured Promissory Note was issued initially for a period of 18 months, expiring January, 2005, and bears interest at the rate of 6.0% per annum.  The Company’s Board of Directors approved the issuance of 200,000 warrants to the major investor as a fee for the issuance of the Note and in the 2nd quarter of 2004 approved the issuance of an additional 200,000 warrants as a fee for extending the note to July 31, 2006.  The warrants are exercisable at $0.425 per share and $1.08 per share, respectively, approximately a 15% discount to market, and expire in March 2008 and May 2008.  The Note is secured by all assets of the Company.

 

At the end of the fourth quarter of 2003 the Company received $1,500,000 in proceeds from the issuance of a Subordinated Convertible Promissory Note.  The Note is due in January 2006 and bears an interest rate of 6%.  The note was amended in 2004 to clarify its conversion features.  Interest accrues yearly and along with principal may be converted into Common Stock, and/or securities convertible into Common Stock, at a conversion rate equal to the purchase price of stock issued, and/or securities issued that are convertible into Common Stock, for cash after the date of the Note to an unrelated third party investor, or if no such issuance takes place within twelve months of the date of the Note, at a price mutually agreed upon as fair value by the Issuer and Holder.  The Holder of the Note is a major shareholder of the Company.  The proceeds from the Note are intended for use in the Company’s acquisition program.

 

6



 

In April 2004 the Company received $1,000,000 in proceeds from the issuance of a Subordinated Convertible Promissory Note.  The Note is due in March 2007 and bears an interest rate of 6%.  Interest accrues yearly and along with principal may be converted into Common Stock, (and/or securities convertible into common shares), at a conversion rate equal to the purchase price of stock issued (and/or securities issued that are convertible into Common Stock) for cash after the date of the Note to an unrelated third party investor, or if no such issuance takes place within twenty four months of the date of the Note, at a price mutually agreed upon as fair value by the Issuer and Holder.  The Holder of the Note is a major shareholder of the Company.

 

The conversion of the above convertible notes in the aggregate principal amount of $3,500,000 is subject to a conversion price equal to the price at which equity is first raised for cash after the issuance of the notes.  During the 2nd quarter of 2004 the Company entered into an agreement to raise equity via a private placement, as described in the Capital and Liquidity Resources section. As a result of the private placement, the Notes are now convertible into an aggregate of 3,500,000 Units consisting of 3,500,000 shares of common stock and Warrants to acquire 2,625,000 shares of common stock at a price of $1.35 per share.

 
Critical Accounting Policies

 

Our significant accounting polices are described in Note 1 of the consolidated financial statements, that were prepared in accordance with accounting principles generally accepted in the United States of America.  In preparing our financial statements we made estimates and judgments that affect the results of our operations and the value of assets and liabilities we report.  Our actual results may differ from these estimates under different assumptions or conditions.

 

For additional information regarding our critical accounting policies and estimates, see the section entitled “Managements Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2003.

 

ITEM 2.                             MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION

 

This Quarterly Report contains forward-looking statements as that term is defined in the federal securities laws.  The Company wishes to insure that any forward-looking statements are accompanied by meaningful cautionary statements in order to comply with the terms of the safe harbor provided by the Private Securities Litigation Reform Act of 1995.  The events described in the forward-looking statements contained in this Quarterly Report may not occur.  Generally these statements relate to business plans or strategies, projected or anticipated benefits or other consequences of our plans or strategies, projected or anticipated benefits of acquisitions to be made by us, projections involving anticipated revenues, earnings, or other aspects of our operating results.  The words “may”, “will”, “expect”, “believe”, “anticipate”, “project”, “plan”, “intend”, “estimate”, and “continue”, and their opposites and similar expressions are intended to identify forward-looking statements.  We caution you that these statements are not guarantees of future performance or events and are subject to a number of uncertainties, risks, and other influences, many of which are beyond our control, that may influence the accuracy of the statements and the projections upon which the statements are based.  Actual results may vary from these forward-looking statements for many reasons, including the following factors: adverse changes in economic or industry conditions in general or in the markets served by the Company and its customers, actions by competitors, and inability to add new customers and/or maintain customer relationships.  The foregoing is not intended to be an exhaustive list of all factors that could cause actual results to differ materially from those expressed in forward-looking statements made by the Company.  Investors are encouraged to review the risk factors set forth in the Company’s most recent Form 10-K as filed with the Securities and Exchange Commission, for the year ended December 31, 2003, in March 2004.  Any one or more of these uncertainties, risks, and other influences could materially affect our results of operations and whether forward-looking statements made by us ultimately prove to be accurate.  Our actual results, performance and achievements could differ materially from those expressed or implied in these forward-looking statements.  We undertake no obligation to publicly update or revise any forward looking statements, whether from new information, future events, or otherwise.

 

Readers are further cautioned that the Company’s financial results can vary from quarter to quarter, and the financial results for any period may not necessarily be indicative of future results.

 

7



 

RESULTS OF OPERATIONS

 

The following discussion and analysis should be read in conjunction with the Company’s unaudited consolidated financial statements presented elsewhere herein.  The discussion of results should not be construed to imply any conclusion that such results will necessarily continue in the future.

 

Total Revenues

 

Total sales for the three months ended September 30, 2004 were $2,582,000 as compared with total sales of $1,406,000 for the same three months in 2003; up 84%.  Total sales for the nine months ended September 30, 2004 were $6,305,000 as compared with $3,754,000 for the same period last year; up 68%.  Of the approximately $2.5 million increase in year-to-year revenue in the first nine months, approximately 33% is directly attributable to the acquisition of Laser Optics, Inc., while the remaining 67% of the increase is attributable to synergies realized from that acquisition and to increased demand for the Company’s product.

 

 Sales of custom optical components by the “new” Laser Optics (the business unit formed in December 2003 from the merger of the assets of Laser Optics, Inc. and those of INRAD custom optics) continued strong to customers in the aerospace, defense, and process control and metrology sectors.  Sales to three OEMs accounted for 40% of total revenues.  One customer is a major defense industry OEM; the other two are major process control and metrology industry OEMs.

 

Sales of INRAD laser accessories to both OEMs and researchers was stronger this quarter than in the same period a year ago, up 130%.  Deliveries of INRAD custom optical components to defense sector OEMs remained strong during the quarter with sales to one customer representing 12% of total revenues.  .

 

Bookings for the third quarter were $3,231,000 as compared with.  $2,056,000 for the same period last year, up 57%.  Bookings for the first nine months were $8,660,000 vs. $4,968,000 for the same period in 2003, up 74%.

 

The book-to-bill ratio for the third quarter of 2004 was 1.25 and the book-to-bill ratio for the first nine months of 2004 was 1.37.  This compares with a ratio of 1.12 for all of 2003, indicating continuing stronger demand from the Company’s customer base for its products.  However, customer and competitive pressures continue to cause us to hold our prices firm in most instances.

 

In this year’s third quarter, OEM order intake was strong for custom optical components from both INRAD and Laser Optics, and for INRAD laser accessories.  Orders from four major OEM customers accounted for 58% of the total bookings in this quarter.  Two of these customers are major defense industry OEMs, both INRAD and Laser Optics customers.  The other two are major process control and metrology sector major OEMs, customers of our Laser Optics business unit.

 

The backlog at September 30, 2004 was up 129% to $4,333,000 as compared to $1,890,000 on September 30, 2003.  The Backlog increased 90% during the first nine months of 2004, up from $2,286,000 on December 31, 2003.  Bookings in the first half of the year usually include OEM orders from INRAD customers placed in the first half for goods deliverable over the coming twelve months.  Due to this trend, the bookings in the second half of 2004 are not anticipated to equal those in the first half.

 

The backlog on September 30, 2004 indicates higher sales than in 2003 are anticipated in the 4th quarter.

 

Cost of Goods Sold

 

For the nine-month period ended September 30, 2004, the cost of goods sold as a percentage of product revenues was 73.7% vs. 80.0% for the same period last year.  For the full year 2003, the actual cost of good sold percentage was 83.9%.  Gross profit margin for the first nine months was 26.3%, compared with 20.0% for the first nine months of 2003.

 

In dollar terms, the cost of goods sold was $4,649,000 for the first nine months of 2004 compared with $2,967,000 for first nine months of 2003, up 56.7%.  Product revenues were up 69.1% year to year for the same period.

 

The increase in the total cost of goods sold in comparison to 2003 was the result of increased costs for material and personnel associated with increased sales volumes.  The increase in gross profit margin is primarily due to the impact of increased volumes coupled with cost savings realized from the consolidation of the Laser Optics, Inc. Bethel, CT. facility into Northvale.

 

Inventory costs for the year were determined from perpetual inventory records, adjusted to net realizable value.

 

Selling, General and Administrative Expenses

 

Selling, general and administrative expenses for the current nine-month period were $2,007,000 vs. $1,665,000 for the same period in the prior year, up 20.5%.  Third quarter expenses were $646,000 for the current year vs. $571,000 for the third quarter of FY 2003.  The expenses increased for the year due to inclusion of general management and sales personnel costs resulting from the acquisition of Laser Optics, Inc., and the restoration of certain executive salaries to pre September 2002 levels.

 

8



 

Internal Research and Development Expenses

 

Research and development expenses for the quarter ended September 30, 2004 were $24,000 compared to $35,000 for the quarter ended September 30, 2003.  IR&D expenditures for the first nine months of 2004 were $76,000 compared to $116,000 in the first nine months of 2003.  The decrease was the result of partially re-focusing engineering efforts to production in 2004.

 

Interest expense

 

Interest expense for the first nine months of the year was $238,000 compared to $165,000 incurred in the first nine months of 2003.  Interest expense increased over prior periods due to the increased borrowing needs experienced by the Company, and 1.5% higher interest rates.  Borrowing needs increased due to the need for capital for the Laser Optics acquisition and other anticipated acquisitions.  During 2003, a secured note in the principal amount of $1,700,000 at 6.0% interest was issued to pay off bank debt that was at rates approximating the prime rate of interest of 4.5% to 5.61%.  In 2003, a $1,500,000 subordinated convertible note, at 6% interest, and in 2004 a $1,000,000 subordinated convertible note, at 6% interest, were issued to provide funds for acquisition purposes.  Interest on the secured and convertible notes is accrued, and payment, in either stock or cash, is due upon the maturity of the notes.

 

Net Profit

 

Net loss for the nine months ended September 30, 2004 was $(660,000) compared to a net loss of $(1,177,000) in the same period in FY 2003.  Net profit for the quarter ending September 30, 2004 was $95,000 compared to a net loss of $(380,000) for the third quarter of 2003.

 

Losses from operations for the first nine months was $(428,000) in 2004 as compared with $(1,013,000) in 2003.  The third quarter operating profit was $177,000 in 2004 compared to an operating loss of $(320,000) in the third quarter of 2003.

 

Earnings Per Share

 

Basic earnings per share available to common shareholders was calculated by adjusting the net loss by $165,000 in 2004, and by $54,000 in 2003, for the common stock dividend paid on Company preferred stock, divided by the weighted shares outstanding.  Diluted earnings per share for the nine months ended September 30, 2004 and the three and nine months ended September 30, 2003 were not calculated because the effect of outstanding options, warrants and convertible securities was anti-dilutive.

 

LIQUIDITY AND CAPITAL RESOURCES

 

Capital expenditures, including purchases and a portion of applicable internal labor and overhead charges, for the nine months ended September 30, 2004 and 2003 were $911,000 and $86,000, respectively.  Capital expenditures for all of 2003 were $101,000.  The increase in costs represent expenditures for new capital equipment used in manufacturing operations, replacement of capital equipment at the end of its useful life, the rearrangement of the Northvale, NJ facility to efficiently and functionally incorporate the 11,000 square feet of contiguous floor space leased at the end of 2003, and for the merge-in of manufacturing operations previously located at the former Bethel, Connecticut location of Laser Optics, Inc.

 

Management intends to continue to make investments in capital acquisitions from time to time, both in equipment and acquisition of complementary businesses, to pursue its objective of growth in shareholder value and to maintain a competitive edge in the markets that it serves.  However, there can be no assurances that any acquisitions will be consummated, or that additional capital infusions will be obtained.

 

The Company currently has capital on-hand to continue its acquisition plan for the near term.  The Company continues to search for additional sources for infusion of capital to be used for additional acquisitions to follow.

 

During the nine month period ended September 30, 2004, cash outflows were funded from positive cash flows from operations and cash proceeds from a subordinated convertible promissory note received in 2002.  Where possible, the Company will seek to increase sales, and improve margins to improve future operating results and cash flows.  Management expects that cash flow from operations and use of its existing cash reserves, will provide adequate liquidity for the Company’s operations in 2004.  The current nine month period yielded positive cash flow from operations in the amount of $268,000.

 

At the end of the fourth quarter of 2002 the Company received $1,000,000 in proceeds from the issuance of a Subordinated Convertible Promissory Note.  The Note is due in January 2006 and bears an interest rate of 6%.  The note was amended in 2004 to clarify its conversion features.  Interest accrues yearly and along with principal may be converted into Common Stock, (and/or securities convertible into common shares), at a conversion rate equal to the purchase price of stock issued (and/or securities issued that are convertible into Common Stock) for cash after the date of the Note to an unrelated third party investor, or if no such issuance

 

9



 

takes place within twenty four months of the date of the Note, at a price mutually agreed upon as fair value by the Issuer and Holder.  The Holder of the Note is a related party to a major shareholder of the Company.

 

In January 2003 the Company was in violation of certain financial covenants required under its loan agreements.  As a result Wachovia Bank sold both the asset based loan and working capital revolver to APC Investments.  In June of 2003 the Company paid off the loan held by APC with $1,700,000 in proceeds received from the issuance of a Secured Promissory Note that is held by a major investor in the Company.  The Secured Promissory Note was issued initially for a period of 18 months, expiring January 31, 2005, and bears interest at the rate of 6.0% per annum.  The Company’s Board of Directors approved the issuance of 200,000 warrants to the major investor as a fee for the issuance of the Note and in the 2nd quarter of 2004 approved the issuance of an additional 200,000 warrants as a fee for extending the note to July 31, 2006.  The warrants are exercisable at $0.425 per share and $1.08 per share, respectively, approximately a 15% discount to market, and expire in March 2008 and May 2008.  The warrants are included in the financial statements of the Company at a determined fair value of $162,000 that will be amortized over the life of the loan.  The Note is secured by all assets of the Company.

 

At the end of the fourth quarter of 2003 the Company received $1,500,000 in proceeds from the issuance of a Subordinated Convertible Promissory Note.  The Note is due in January 2006 and bears an interest rate of 6%.  The note was amended in 2004 to clarify its conversion features.  Interest accrues yearly and along with principal may be converted into Common Stock, and/or securities convertible into Common Stock, at a conversion rate equal to the purchase price of stock issued, and/or securities issued that are convertible into Common Stock, for cash after the date of the Note to an unrelated third party investor, or if no such issuance takes place within twelve months of the date of the Note, at a price mutually agreed upon as fair value by the Issuer and Holder.  The Holder of the Note is a major shareholder of the Company.  The proceeds from the Note are intended for use in the Company’s acquisition program.

 

In April 2004 the Company received $1,000,000 in proceeds from the issuance of a Subordinated Convertible Promissory Note.  The Note is due in March 2007 and bears an interest rate of 6%.  Interest accrues yearly and along with principal may be converted into Common Stock, (and/or securities convertible into common shares), at a conversion rate equal to the purchase price of stock issued (and/or securities issued that are convertible into Common Stock) for cash after the date of the Note to an unrelated third party investor, or if no such issuance takes place within twenty four months of the date of the Note, at a price mutually agreed upon as fair value by the Issuer and Holder.  The Holder of the Note is a major shareholder of the Company.

 

The conversion of the above convertible notes in the aggregate principal amount of $3,500,000 is subject to a conversion price equal to the price at which equity is first raised for cash after the issuance of the notes.  During the 2nd quarter of 2004 the Company entered into an agreement to raise equity via a private placement, as described in the Capital and Liquidity Resources section.  As a result of the private placement, the Notes are now convertible into an aggregate of 3,500,000 Units consisting of 3,500,000 shares of common stock and Warrants to acquire 2,345,000 shares of common stock at a price of $1.35 per share.

 

During the 2nd quarter of 2004 the Company entered into an agreement with an investment banking firm to raise equity via a private placement that was exempt from registration with the Securities and Exchange Commission.  In July 2004, the Company issued 1,581,000 Units, at a purchase price of $1.00 per unit, consisting of 1,581,000 shares of common stock and warrants to acquire an additional 1,185,750 shares at $1.35 per share.  The Company also issued 276,675 warrants at an exercise price of $1.35 to the placement agent engaged for the private offering.  This resulted in net proceeds to the Company of approximately $1,199,000.  The funds are to be utilized in the furtherance to the company’s M&A program, capital equipment purchases and to meet general working capital requirements.  The conversion of the above convertible notes in the aggregate principal amount of $3,500,000 is subject to a conversion price equal to the price at which equity is first raised for cash.  As a result of the private placement the Notes are now convertible into an aggregate of 3,500,000 Units consisting of 3,500,000 shares of common stock and Warrants to acquire 2,625,000 shares of common stock at a price of $1.35 per share.

 

Subsequent Event

 

On October 19, 2004 the Company entered into a definitive stock purchase agreement with Frank E. Montone to acquire all the issued stock of MRC Precision Metal Optics, Inc., a Florida corporation (“MRC”) and closed on such transaction on the same date.  MRC is principally engaged in the business of producing precision optics and assemblies principally for customers in the domestic and foreign commercial, aerospace and military markets.

 

The purchase price for MRC’s stock was $525,000 plus earn-out payments of up to $300,000 payable over 5 years.  The purchase price was paid by the combination of a cash payment and the issuance of a note in the principal sum of $175,000 bearing interest at 6% per annum.  Mr. Montone also received an employment agreement and agreed to a covenant not to compete.

 

In accordance with management’s expectations, the acquisition of MRC is expected to increase sales in the 4th quarter and to be accretive to profit over the coming year.  During this same period PPGI will provide MRC with approximately $400,000 to fund working capital requirements for inventory and trade receivables, and thereby impacting 4th quarter cash flow from operations.

 

10



 

Management expects that cash flow from operations and use of its existing cash reserves, will provide adequate liquidity for the Company’s operations through 2005 after accounting for the acquisition of MRC.

 

ITEM 3.                             QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

The Company believes that it has limited exposure to changes in interest rates from investments in certain money market accounts.  The Company does not utilize derivative instruments or other market risk sensitive instruments to manage exposure to interest rate changes.  The Company believes that a hypothetical 100 basis point adverse move in interest rates along the entire interest rate yield curve would not materially affect the fair value of the Company’s interest sensitive money market accounts at September 30, 2004.

 

ITEM 4.

 

Within the 90 days prior to the date of this report, the Corporation carried out an evaluation, under the supervision and with the participation of the Corporation’s management, including the Corporation’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Corporation’s disclosure controls and procedures pursuant to Securities Exchange Act Rule 13a-14.  Based upon that evaluation, the Corporation’s Chief Executive Officer and Chief Financial Officer concluded that the Corporation’s disclosure controls and procedures are effective in timely alerting them to material information relating to the Corporation (including its consolidated subsidiaries) required to be included in the Corporation’s periodic SEC filings.

 

There have been no significant changes in the Corporation’s internal controls or in other factors that could significantly affect internal controls subsequent to the date of their evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

 

11



 

PART II.    OTHER INFORMATION

 

ITEM 2.          CHANGES IN SECURITIES, USE OF PROCEEDS AND ISSUER PURCHASES OF EQUITY SECURITIES

 

Refer to Form S-1 filed with the Securities and Exchange Commission by the Company on August 25, 2004.

 

ITEM 4.          SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

 

On August 25, 2004 the Annual Meeting of Shareholders was held for shareholders of record as of June 30, 2004.  The meeting was held at the offices of Lowenstein Sandler, PC, 65 Livingston Avenue, New Jersey.  The following are the results of the shareholder vote:

 

1.               With respect to the increase in the total Common Shares authorized to 60,000,000 shares:

 

SHARES VOTED

IN FAVOR

 

AGAINST

 

ABSTAINED

3,171,819

 

400

 

1,255,550

 

2.  With respect to the increase in the total Common Shares available for issuance under the 2000 Equity Compensation Program to 6,000,000 shares:

 

SHARES VOTED

IN FAVOR

 

AGAINST

 

ABSTAINED

3,159,304

 

1,229,915

 

8,550

 

3. With respect to the election of two Class I Directors, two Class II Directors, and one Class III Director to hold office for 1, 3, and 2 years respectively:

 

 

 

SHARES VOTED

 

 

 

 

 

AUTHORITY

 

 

 

IN FAVOR

 

WITHHELD

 

Thomas Lenagh

 

2,929,592

 

2,700

 

Daniel Lehrfeld

 

2,929,577

 

2,715

 

Frank Wiedeman

 

2,929,592

 

2,700

 

Jan Winston

 

2,929,592

 

2,700

 

John Rich

 

2,929,592

 

2,700

 

 

12



 

ITEM 6.          EXHIBITS AND REPORTS ON FORM 8-K

 

(A)                    Exhibits:

 

11.       An exhibit showing the computation of per-share earnings is omitted because the computation can be clearly determined from the material contained in this Quarterly Report on Form 10-Q.

 

31.1               Certification of Principal Executive Officer pursuant to rule 13a-14(a)/15d-14(a)

 

31.2               Certification of Principal Financial Officer pursuant to rule 13a-14(a)/15d-14(a)

 

The following exhibits shall not be deemed “filed” for purposes of Section 18 of the Securities and Exchange Act of 1934 or otherwise subject to the liability of that Section.  In addition Exhibit No. 32 shall not be deemed incorporated into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934.

 

32.1     Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350

 

32.2     Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350

 

(B)                      Reports on Form 8-K:

 

                                  On July 12, 2004, under Item 5, Other Events, summarizing the first closing of a private placement.

 

                                  On September 22, 2004, Under Item 7.01, FD Regulation Disclosure, summarizing the resignation of a corporate officer.

 

                                  On October 25, 2004, Under Item 1.01, Entry Into a Material Definitive Agreement and Item 2.01 Completion of Acquisition or Disposition of Assets, summarizing the acquisition of 100% wholly owned subsidiary.

 

13



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized

 

 

Photonic Products Group, Inc.

 

 

 

 

By:

/s/ Daniel Lehrfeld

 

 

Daniel Lehrfeld

 

 

President and Chief Executive Officer

 

 

 

 

By:

/s/ William S. Miraglia

 

 

William S. Miraglia

 

 

Chief Financial Officer

 

Date:    November 11, 2004

 

14